STOCK TITAN

DarioHealth to Participate in the Virtual 18th Annual Craig-Hallum Institutional Investor Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

DarioHealth Corp. (Nasdaq: DRIO) will participate in the 18th Annual Craig-Hallum Institutional Investor Conference on June 2. CEO Erez Raphael and President Rick Anderson will host meetings with registered investors. DarioHealth is a leader in digital therapeutics, focusing on chronic condition management through AI-powered solutions. Their tools promote behavioral change and improve health outcomes, with a strong reputation in diabetes and hypertension care. For more information, visit dariohealth.com.

Positive
  • None.
Negative
  • None.

NEW YORK, May 26, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that management will participate in the 18th Annual Craig-Hallum Institutional Investor Conference, which is being held virtually on Wednesday, June 2.  

 

DarioHealth Logo

 

Erez Raphael, Chief Executive Officer, and Rick Anderson, President and General Manager of North America, will host investor 1x1 and small group meetings with registered attendees.

About DarioHealth Corp.

DarioHealth Corp. (Nasdaq: DRIO) is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. Dario's next-generation, AI-powered, digital therapeutic solutions support more than just an individual's disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions, intuitive, clinically proven digital tools, high-quality software, and coaching to help individuals improve health and sustain meaningful outcomes. Dario offers one of the highest-rated diabetes and hypertension solutions on the market. The company's cross-functional team operates at the intersection of life sciences, behavioral science, and software technology and is rapidly expanding into new chronic conditions and geographic markets, using a performance-based approach to improve its users' health. Dario makes the right thing to do the easy thing to do. To learn more about DarioHealth and its digital health solutions, or for more information, visit http://dariohealth.com.    

DarioHealth Corporate Contact:
Suzanne Bedell
VP Marketing
suzanne@dariohealth.com
+1-347-767-4220

Investor Relations Contact:
Chuck Padala
chuck@lifesciadvisors.com
+1-646-627-8390

Media Contact:
Josephine Galatioto
Josephine.galatioto@russopartnersllc.com
+1-212-845-4262

Cision View original content:http://www.prnewswire.com/news-releases/dariohealth-to-participate-in-the-virtual-18th-annual-craig-hallum-institutional-investor-conference-301299799.html

SOURCE DarioHealth Corp.

FAQ

When is DarioHealth participating in the investor conference?

DarioHealth will participate in the 18th Annual Craig-Hallum Institutional Investor Conference on June 2, 2021.

Who will represent DarioHealth at the conference?

CEO Erez Raphael and President Rick Anderson will represent DarioHealth at the conference.

What is DarioHealth's stock symbol?

DarioHealth's stock symbol is DRIO.

What does DarioHealth specialize in?

DarioHealth specializes in digital therapeutics for managing chronic conditions.

What are DarioHealth's strengths in digital health solutions?

DarioHealth offers AI-powered tools that provide personalized experiences and evidence-based interventions.

DarioHealth Corp.

NASDAQ:DRIO

DRIO Rankings

DRIO Latest News

DRIO Stock Data

24.68M
34.10M
17.7%
23.54%
5.88%
Health Information Services
Surgical & Medical Instruments & Apparatus
Link
United States of America
NEW YORK